Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Inkeri Elomaa"'
Autor:
Matti Mäntylä, Inkeri Elomaa, Johanna Mattson, Pia Lindroos, Dick Killander, Bo Littbrand, Jens Overgaard, Mikko Tenhunen
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/5a6e7ed428e4445e8d5cc01a172585ec
Publikováno v:
Acta Oncologica. 53:75-79
Premenopausal patients treated with adjuvant chemotherapy often develop early menopause and thus, may encounter significant bone loss. We studied the long-term effects of chemotherapy-induced ovarian dysfunction on bone mineral density in breast canc
Autor:
Kimmo Mattila, Heikki Minn, Aarne Kivioja, Vesa Oikonen, Markku Kallajoki, Paula Lindholm, Inkeri Elomaa, Eija Sutinen, Tom Böhling, Maija Tarkkanen, Hannu T. Aro
Publikováno v:
Nuclear Medicine and Biology. 38:295-300
Introduction Little is known about blood flow in sarcomas. Our purpose was to study glucose metabolism and blood flow in untreated localized musculoskeletal tumors of the extremities using [ 18 F]fluorodeoxyglucose (FDG), oxygen-15 labeled water ([15
Publikováno v:
Acta Medica Scandinavica. 214:87-91
Amyloidosis is known to occur both in renal adenocarcinoma and multiple myeloma. This paper describes a 52-year-old man who developed multiple myeloma and widespread amyloidosis after surgical removal of a hypernephroma. Multiple myeloma presented wi
Publikováno v:
Acta Medica Scandinavica. 216:323-326
Vascular symptoms after vinca-alcaloids and bleomycin are known. We report a 50-year-old woman who was cigarette smoker and who had had the syndrome of Raynaud's phenomenon for two years before she developed non-Hodgkin lymphoma. She was treated with
Autor:
Heikki Joensuu, Maija Saxelin, M. Kouri, Tarja Ruotsalainen, A Ollus, Inkeri Elomaa, Pia Österlund, Päivi Valta, Riitta Korpela
Publikováno v:
British Journal of Cancer
5-Fluorouracil (5-FU)-based chemotherapy is frequently associated with diarrhoea. We compared two 5-FU-based regimens and the effect of Lactobacillus and fibre supplementation on treatment tolerability. Patients diagnosed with colorectal cancer (n=15
Publikováno v:
Calcified Tissue International. 77:84-90
Bisphosphonates have been used successfully in the treatment of malignant hypercalcemia and skeletal metastases. Recently, clodronate has been studied in adjuvant settings in primary breast cancer. However, long-term effect of adjuvant clodronate on
Publikováno v:
Breast Cancer Research and Treatment. 90:117-125
Purpose. Serum postoperative matrix metalloproteinase 2 (MMP-2) level is a predictor of outcome in node positive breast cancer and can be used to stratify patients into low and high risk groups. Our aim was to determine how clodronate treatment influ
Lactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancer
Autor:
Tarja Ruotsalainen, Inkeri Elomaa, Riitta Korpela, Pia Österlund, Katri Peuhkuri, Heikki Joensuu, Minna Ikonen, Anneli Ollus
Publikováno v:
Clinical Gastroenterology and Hepatology. 2:696-703
Bowel mucosal injury associated with 5-fluorouracil (5-FU) treatment might result in secondary lactose intolerance. The frequency and clinical significance of 5-FU-related hypolactasia are unknown.One hundred fifty patients randomly assigned to recei
Publikováno v:
British Journal of Cancer
In all, 146 premenopausal women with early stage breast cancer were treated with adjuvant chemotherapy. In addition, 5-year tamoxifen treatment was started after chemotherapy to those 112 patients with hormone-receptor-positive tumours while those wi